323 related articles for article (PubMed ID: 24768604)
21. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
22. [Neonatal lupus and maternofetal transmission of anti-SSA/Ro and anti-SSB/La antibodies].
Feki S; Turki A; Frikha F; Hachicha H; Walha L; Gargouri A; Bahloul Z; Masmoudi H
Arch Pediatr; 2015 Feb; 22(2):154-9. PubMed ID: 25440767
[TBL] [Abstract][Full Text] [Related]
23. Detection and identification of significant ANAs in previously determined ANA negative samples.
Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
[TBL] [Abstract][Full Text] [Related]
24. Specific testing for "isolated" anti-52 kDa SSA/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value.
Langguth DM; Morris S; Clifford L; Wilson RJ; Neil J; Hogan PG; Wong RC
J Clin Pathol; 2007 Jun; 60(6):670-3. PubMed ID: 17557869
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to Both Ro52 and Ro60 for Identifying Sjögren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies.
Armağan B; Robinson SA; Bazoberry A; Perin J; Grader-Beck T; Akpek EK; Kim J; Baer AN
Arthritis Care Res (Hoboken); 2022 Sep; 74(9):1559-1565. PubMed ID: 33742788
[TBL] [Abstract][Full Text] [Related]
26. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A
Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891
[TBL] [Abstract][Full Text] [Related]
27. Anti-SSA/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study.
Sánchez-Montalvá A; Fernández-Luque A; Simeón CP; Fonollosa-Plà V; Marín A; Guillén A; Vilardell M
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-177-82. PubMed ID: 25372801
[TBL] [Abstract][Full Text] [Related]
28. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
[TBL] [Abstract][Full Text] [Related]
29. Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
Zampeli E; Mavrommati M; Moutsopoulos HM; Skopouli FN
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):134-141. PubMed ID: 32083547
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype.
Peene I; Meheus L; Veys EM; De Keyser F
Ann Rheum Dis; 2002 Dec; 61(12):1090-4. PubMed ID: 12429541
[TBL] [Abstract][Full Text] [Related]
31. Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome.
Yamaguchi K; Tang Q; Poland P; Reay DP; Gregory A; Aggarwal R; Oddis CV; Ascherman DP
Front Immunol; 2024; 15():1399451. PubMed ID: 38895121
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.
Ghillani P; André C; Toly C; Rouquette AM; Bengoufa D; Nicaise P; Goulvestre C; Gleizes A; Dragon-Durey MA; Alyanakian MA; Chretien P; Chollet-Martin S; Musset L; Weill B; Johanet C
Autoimmun Rev; 2011 Jul; 10(9):509-13. PubMed ID: 21447407
[TBL] [Abstract][Full Text] [Related]
33. Seronegative patients with primary Sjögren's syndrome and non-pSS sicca test positive for anti-SSA/Ro52 and -Ro60 in saliva.
Kamounah S; Wei F; Park JK; Song YW; Chia D; Wong DTW; Pedersen AML
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167168. PubMed ID: 38641012
[TBL] [Abstract][Full Text] [Related]
34. Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis.
Montano-Loza AJ; Shums Z; Norman GL; Czaja AJ
Liver Int; 2012 Jan; 32(1):85-92. PubMed ID: 21745277
[TBL] [Abstract][Full Text] [Related]
35. Transfection, overexpression and clinical application of human 60 kDa Ro/SSA autoantigens in HEp-2 cells.
Lu L; Chen S; Gu Y; Shen N; Bao C; Wang Y; Xue F; Ye P; Yu C
Chin Med J (Engl); 2003 Mar; 116(3):350-3. PubMed ID: 12781035
[TBL] [Abstract][Full Text] [Related]
36. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases].
Duran A; Çetin Duran A; Taşkıran İ
Mikrobiyol Bul; 2022 Jan; 56(1):81-94. PubMed ID: 35088962
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies to the functionally active RING-domain of Ro52/SSA are associated with disease activity in patients with lupus.
Kvarnström M; Dzikaite-Ottosson V; Ottosson L; Gustafsson JT; Gunnarsson I; Svenungsson E; Wahren-Herlenius M
Lupus; 2013 Apr; 22(5):477-85. PubMed ID: 23554036
[TBL] [Abstract][Full Text] [Related]
38. Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome.
Aqrawi LA; Skarstein K; Øijordsbakken G; Brokstad KA
Clin Exp Immunol; 2013 May; 172(2):228-37. PubMed ID: 23574319
[TBL] [Abstract][Full Text] [Related]
39. Routine immunofluorescence detection of Ro/SS-A autoantibody using HEp-2 cells transfected with human 60 kDa Ro/SS-A.
Pollock W; Toh BH
J Clin Pathol; 1999 Sep; 52(9):684-7. PubMed ID: 10655991
[TBL] [Abstract][Full Text] [Related]
40. Anti-SSA Ro52 and anti-Ro60 autoantibodies: association with clinical phenotypes.
Mazeda C; Oliveira N; Abreu C; Fraga V; Maduro I; Saraiva A; Inês L; Ferreira C; Correia AM; Nicolau R; Farinha F; Villanueva I; Jesus D; Abreu P; Neto A; Silva Dinis J; Barcelos A
Clin Exp Rheumatol; 2024 Mar; ():. PubMed ID: 38530658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]